FREE Case Review (866) 588-0600

Mississippi Tepezza Lawsuit Attorney

Award Logos
Awards & recognition
C.L. Mike Schmidt Published by C.L. Mike Schmidt

The Mississippi Tepezza Lawsuit is a class action lawsuit where people in Mississippi claim that they experienced hearing loss after taking the prescription medication Tepezza.

The main issue here is that the drug manufacturer, Horizon Therapeutics, allegedly didn’t provide sufficient warning about the possibility of hearing loss. As a result, many people have been filing Tepezza lawsuits, the cases have been combined, and a special master was appointed to manage the litigation.

Should you or a family member have been impacted by Tepezza, leading to complications such as hearing loss, Schmidt & Clark, LLP is prepared to provide you with assistance. As a nationally renowned legal firm with a focus on plaintiffs’ cases, our main goal is to guarantee that you receive the justice and compensation you justly merit.

Mississippi Tepezza Lawsuits

Tepezza is a medication used to treat thyroid eye disease (TED). It’s also known as Graves’ eye disease. Unfortunately, a significant number of patients who took the drug experienced permanent hearing problems, such as hearing loss and tinnitus, leading to the filing of Tepezza lawsuits.

In Mississippi, multiple Tepezza hearing loss lawsuits have been filed against Horizon Therapeutics, the manufacturer of Tepezza. These lawsuits allege that the company failed to adequately warn patients about the risk of permanent hearing damage associated with the drug. The plaintiffs seek compensation for medical expenses, lost wages, and other damages resulting from their hearing impairment.

Plaintiffs’ Claims and Horizon’s Defense

The plaintiffs in the Tepezza lawsuits claim that Horizon did not provide sufficient warning about the potential risk of permanent hearing damage resulting from Tepezza use. They argue that the company did not inform doctors of the need to monitor patients’ hearing during Tepezza infusions, nor did they conduct adequate testing before receiving FDA approval.

Additionally, plaintiffs accuse Horizon of exaggerating the number of people who could benefit from the medication.

In response, Horizon Therapeutics argues that the plaintiffs’ claims should be dismissed based on the federal preemption doctrine. This legal principle states that federal law takes precedence over state law in certain cases, potentially shielding Horizon from liability. The outcome of this defense strategy remains to be seen as the litigation process continues to unfold.

Recent Developments in Tepezza Litigation

In an effort to streamline the legal process, the filing of Tepezza lawsuits has been combined into one multidistrict litigation (MDL) in the Northern District of Illinois. As of now, there are around 46 cases in the MDL, and the Mississippi Tepezza hearing loss lawsuits are still in the early stages, with no trials or court-approved settlements as of July 2023.

It is vital for those affected to keep up-to-date with the evolving Tepezza litigation. The results of these Tepezza hearing damage lawsuits could greatly impact patients who have suffered hearing loss or tinnitus following Tepezza use and could influence the broader pharmaceutical sector.

What Is Tepezza?

Tepezza is an injectable drug developed by Horizon Therapeutics, designed as a thyroid eye disease treatment, specifically to treat thyroid eye disease (TED) [1]. TED is a rare autoimmune disorder that causes:

  • Eye pain
  • Redness
  • Swelling
  • Vision problems such as double vision

The condition occurs when the body’s immune system mistakenly attacks the tissues around the eyes, causing inflammation and damage.

The drug works by binding to receptors behind the eyes, which are responsible for causing the swelling and inflammation associated with TED. Tepezza received FDA approval in January 2020, but since then, numerous patients have reported experiencing serious and permanent hearing problems after receiving Tepezza infusions.

Tepezza Side Effects & Hearing Loss

Though Tepezza has shown effectiveness in treating TED, it has also been linked to some concerning side effects, particularly in the realm of hearing health. Patients have reported experiencing permanent hearing issues such as deafness, hearing loss, and tinnitus (ringing in the ears) after using Tepezza.

In fact, around 27% of people who used Tepezza reported developing tinnitus. Additionally, the FDA updated Tepezza warning labels in July 2023 to mention the potential risk of severe hearing impairment, indicating that the issue is a known concern for Tepezza users [2].

Does Tepezza Cause Hearing Problems?

Tepezza does cause hearing problems. There is mounting evidence suggesting a connection between Tepezza use and hearing problems [3].

These findings stand in stark contrast to Horizon’s initial claim that only 10% of Tepezza users might experience hearing loss as a side effect.

As more information comes to light, it becomes increasingly clear that there is a strong link between Tepezza and hearing impairment, leaving many patients seeking compensation and justice through the legal system.

65 percent of patients taking teprotumumab report otologic symptoms. – The Endocrine Society

Potential Settlements and Compensation in Mississippi Tepezza Lawsuits

If the facts of a Tepezza hearing loss case are in the plaintiff’s favor, they could receive an average settlement compensation between $140,000 and $350,000. Compensation may be awarded in the form of reimbursement for medical bills, lost wages, and other related costs accrued as a result of hearing impairment.

Keep in mind that settlements and compensation from Mississippi Tepezza lawsuits can fluctuate, depending on the particulars of each case. Collaboration with a seasoned legal team can ensure plaintiffs secure the rightful compensation for their ordeal and losses.

Who Qualifies to File a Mississippi Tepezza Lawsuit?

Individuals who have taken Tepezza and have experienced permanent hearing loss or tinnitus qualify to file a Mississippi Tepezza lawsuit. Eligibility for filing a lawsuit depends on factors such as the severity of hearing loss and the timing of treatment.

Should you consider yourself a potential candidate for filing a Tepezza lawsuit for hearing loss or tinnitus, it is highly recommended to consult a legal team versed in Tepezza litigation. They can assess your eligibility and steer you through the lawsuit filing procedure.

Filing a Mississippi Tepezza Hearing Loss Lawsuit

To file a Tepezza lawsuit in Mississippi, you’ll need to start by finding a personal injury lawyer with experience in Tepezza litigation. Next, you’ll need to provide any relevant documentation, such as medical records, prescription records, and documents related to your hearing loss.

Your legal counsel will take care of the entire legal process, including:

  1. Filing the complaint
  2. Serving the defendant
  3. Moving through the discovery process
  4. Negotiating a settlement on your behalf, if appropriate

See all related dangerous drug lawsuits our attorneys covered so far.

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

Get Your Free Consultation From Mississippi Tepezza Lawyers

Schmidt and Clark, LLP are here to provide steadfast assistance when you need it most. If you or a loved one has developed permanent hearing loss related to Tepezza, please don’t hesitate to reach out. Our team holds extensive expertise in managing such cases, and we are dedicated to supporting you throughout the entire process.

You should be well informed about your legal rights and the potential eligibility for a Tepezza lawsuit. It’s important to note that our consultations are always provided without charge, and you won’t be subject to any financial obligations unless we secure a favorable outcome for your case.

Connect with Schmidt and Clark today for a comprehensive case evaluation. Allow us to be the trusted partner on your legal journey.

Reference:

  1. https://www.tepezza.com/
  2. https://www.endocrine.org/news-and-advocacy/news-room/featured-science-from-endo-2021/increased-risk-of-hearing-impairment-with-new-thyroid-eye-disease-treatment
  3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058351/

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.